Tim Plaehn's Top 2 Dividend Stocks for the New Year (The Market Cap)

Happy New Year! The 2 Best Dividend Stocks for 2017

Ensure you continue to get this valuable content by whitelisting us (find out how here).

January 2, 2017 Edit Subscriber Profile  |  Unsubscribe  |  Privacy Policy

"My #1 Rule: Don't Buy Options" The sad truth is that options buyers lose money on 7 of every 10 trades. They place high-risk trades, hoping for a big payout. But they lose - a LOT! That's why I don't buy options. Instead, I flip them on their head and do "this" with them. When I do, I make money 85% of the time. I turned $50,000 into $5 million trading options this way and for a limited time, I'm guaranteeing you at least $67,548 per year in profitable options trades if you follow this easy step-by-step process. See how easy it is to collect thousands of dollars in "Free Money" every month.

FEATURE

Tim Plaehn's Top 2 Dividend Stocks for the New Year Last year's picks shot up 30% and 99% and his next two have just as exciting growth potential in the coming year. If you want to own stocks for income but also want strong upside potential, take a look at Tim's two favorite picks for 2017. Buy these two stocks for dividends and growth (click to read)

EDITOR'S PICKS This Little-Known Investment Technique Could Fund Your Retirement [ad] The Dividend Stock That Pays an 18% Yield Like Clockwork OUR TOP INVESTING IDEAS   The 3 Stocks that Will Go from Worst to First in 2017 Take advantage of the stock market phenomenon where the worst performers of the last 12 months tend to become the best performers in the next. Bret Jensen searched through the 25 biggest laggards in the S&P 500 to find the best three stocks for big share price gains. Click to read more 3 Best Buy Healthcare Stocks Too Cheap by Half Easily taking the prize of worst performing sector in 2016, healthcare stocks look set to turnaround in 2017 with a more pro-industry administration in office. The three stocks profiled today sell for much too cheap considering their great growth prospects. Click to read more

© Copyright 1998-2016, Investors Alley Corp. All rights reserved. See Privacy Policy and Terms of Use | Contact Us

 

If you enjoyed reading this email, click here to forward it to a friend or colleague.

You are receiving this message because you registered ignoble.experiment@arconati.us through INO.com Invite Sell - Apr 2014.
Click here to send us comments or questions regarding this mailing. Unsubscribe/update profile using link below.

This message from Investors Alley Corp. is being sent in full accordance with the CAN-SPAM Act.
We respect your privacy and, therefore, this email was sent directly from Investors Alley.  Please review our Privacy Statement and Terms of Use. 
If you no longer wish to receive emails from Investors Alley, please opt-out using the link below.

The opinions in this email and corresponding web sites are neither an offer nor a recommendation to buy or sell any security. Investors Alley Corp. and its affiliates may hold a position in any of the companies mentioned.  Investors Alley Corp. is not a registered investment firm nor a broker/dealer.  We urge you to always conduct your own research and due diligence and obtain professional advice before making any investment decision.

All information contained herein is copyright 2016, Investors Alley Corp.
Investors Alley Corporation | 41 Madison Avenue | 31st Floor | New York, NY  10010

 

Update Your Profile Information | Modify Subscription Settings or Unsubscribe From Emails